Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data.

Pulley JM, Rhoads JP, Jerome RN, Challa AP, Erreger KB, Joly MM, Lavieri RR, Perry KE, Zaleski NM, Shirey-Rice JK, Aronoff DM.

Annu Rev Pharmacol Toxicol. 2019 Jul 23. doi: 10.1146/annurev-pharmtox-010919-023537. [Epub ahead of print]

PMID:
31337270
2.

COMPASS: A Pilot Trial of an Early Palliative Care Intervention for Patients With End-Stage Liver Disease.

Shinall MC Jr, Karlekar M, Martin S, Gatto CL, Misra S, Chung CY, Porayko MK, Scanga AE, Schneider NJ, Ely EW, Pulley JM, Jerome RN, Dear ML, Conway D, Buie R, Liu D, Lindsell CJ, Bernard GR.

J Pain Symptom Manage. 2019 Jul 2. pii: S0885-3924(19)30367-7. doi: 10.1016/j.jpainsymman.2019.06.023. [Epub ahead of print]

PMID:
31276810
3.

Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics.

Wells QS, Gupta DK, Smith JG, Collins SP, Storrow AB, Ferguson J, Smith ML, Pulley JM, Collier S, Wang X, Roden DM, Gerszten RE, Wang TJ.

J Am Coll Cardiol. 2019 May 7;73(17):2195-2205. doi: 10.1016/j.jacc.2019.01.074.

PMID:
31047008
4.

We're not all cut from the same cloth: TAILORing treatments for children with chronic conditions.

Jerome RN, Pulley JM, Edwards TL, Dickerson AB, Conway D, Van Driest SL, Bernard GR, Harris PA.

J Patient Rep Outcomes. 2019 Apr 29;3(1):25. doi: 10.1186/s41687-019-0117-2.

5.

A collaborative, academic approach to optimizing the national clinical research infrastructure: The first year of the Trial Innovation Network.

Bernard GR, Harris PA, Pulley JM, Benjamin DK, Michael J, Ford DE, Hanley DF, Selker HP, Wilkins CH.

J Clin Transl Sci. 2018 Aug;2(4):187-192. doi: 10.1017/cts.2018.319. Epub 2018 Nov 27.

6.

Understanding What Information Is Valued By Research Participants, And Why.

Wilkins CH, Mapes BM, Jerome RN, Villalta-Gil V, Pulley JM, Harris PA.

Health Aff (Millwood). 2019 Mar;38(3):399-407. doi: 10.1377/hlthaff.2018.05046.

7.

Connecting the public with clinical trial options: The ResearchMatch Trials Today tool.

Pulley JM, Jerome RN, Bernard GR, Olson EJ, Tan J, Wilkins CH, Harris PA.

J Clin Transl Sci. 2018 Aug;2(4):253-257. doi: 10.1017/cts.2018.327.

8.

A Phenome-Wide Association Study Uncovers a Pathological Role of Coagulation Factor X during Acinetobacter baumannii Infection.

Choby JE, Monteith AJ, Himmel LE, Margaritis P, Shirey-Rice JK, Pruijssers A, Jerome RN, Pulley J, Skaar EP.

Infect Immun. 2019 Apr 23;87(5). pii: e00031-19. doi: 10.1128/IAI.00031-19. Print 2019 Mar.

PMID:
30782860
9.

The PathLink Acquired Gestational Tissue Bank: Feasibility of Project PLACENTA.

Linder JE, Batey K, Johnston R, Cohen EM, Wang Y, Wang X, Zaleski NM, Rogers LM, McDonald WH, Reyzer ML, Judd A, Goldstein J, Correa H, Pulley J, Aronoff DM.

J Reprod Biotechnol Fertil. 2018;7:14-27.

10.

Reply to Ward and Colleagues' Comment on "Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors".

Jerome RN, Pulley JM, Roden DM, Shirey-Rice JK, Bastarache LA, Bernard G, Ekstrom L, Lancaster WJ, Denny JC.

Drug Saf. 2018 Nov;41(11):1101. doi: 10.1007/s40264-018-0701-z. No abstract available.

PMID:
30066313
11.

Advocating for mutually beneficial access to shelved compounds.

Pulley JM, Jerome RN, Shirey-Rice JK, Zaleski NM, Naylor HM, Pruijssers AJ, Jackson JC, Bernard GR, Holroyd KJ.

Future Med Chem. 2018 Jun 1;10(12):1395-1398. doi: 10.4155/fmc-2018-0090. Epub 2018 May 23. No abstract available.

PMID:
29788759
12.

PregOMICS-Leveraging systems biology and bioinformatics for drug repurposing in maternal-child health.

Goldstein JA, Bastarache LA, Denny JC, Pulley JM, Aronoff DM.

Am J Reprod Immunol. 2018 Aug;80(2):e12971. doi: 10.1111/aji.12971. Epub 2018 May 4.

13.

Calcium channel blockers as drug repurposing candidates for gestational diabetes: Mining large scale genomic and electronic health records data to repurpose medications.

Goldstein JA, Bastarache LA, Denny JC, Roden DM, Pulley JM, Aronoff DM.

Pharmacol Res. 2018 Apr;130:44-51. doi: 10.1016/j.phrs.2018.02.013. Epub 2018 Feb 12.

14.

Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.

Pulley JM, Jerome RN, Ogletree ML, Bernard GR, Lavieri RR, Zaleski NM, Hong CC, Shirey-Rice JK, Arteaga CL, Mayer IA, Holroyd KJ, Cook RS.

Target Oncol. 2018 Feb;13(1):61-68. doi: 10.1007/s11523-017-0542-1. Review.

15.

When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.

Pulley JM, Jerome RN, Zaleski NM, Shirey-Rice JK, Pruijssers AJ, Lavieri RR, Chettiar SN, Naylor HM, Aronoff DM, Edwards DA, Niswender CM, Dugan LL, Crofford LJ, Bernard GR, Holroyd KJ.

Assay Drug Dev Technol. 2017 Dec;15(8):354-361. doi: 10.1089/adt.2017.821. Epub 2017 Dec 1.

16.

Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors.

Jerome RN, Pulley JM, Roden DM, Shirey-Rice JK, Bastarache LA, R Bernard G, B Ekstrom L, Lancaster WJ, Denny JC.

Drug Saf. 2018 Mar;41(3):303-311. doi: 10.1007/s40264-017-0616-0.

17.

Mining 100 million notes to find homelessness and adverse childhood experiences: 2 case studies of rare and severe social determinants of health in electronic health records.

Bejan CA, Angiolillo J, Conway D, Nash R, Shirey-Rice JK, Lipworth L, Cronin RM, Pulley J, Kripalani S, Barkin S, Johnson KB, Denny JC.

J Am Med Inform Assoc. 2018 Jan 1;25(1):61-71. doi: 10.1093/jamia/ocx059.

18.

Recruitment methods for survey research: Findings from the Mid-South Clinical Data Research Network.

Heerman WJ, Jackson N, Roumie CL, Harris PA, Rosenbloom ST, Pulley J, Wilkins CH, Williams NA, Crenshaw D, Leak C, Scherdin J, Muñoz D, Bachmann J, Rothman RL, Kripalani S.

Contemp Clin Trials. 2017 Nov;62:50-55. doi: 10.1016/j.cct.2017.08.006. Epub 2017 Aug 17.

PMID:
28823925
19.

Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics.

Pulley JM, Shirey-Rice JK, Lavieri RR, Jerome RN, Zaleski NM, Aronoff DM, Bastarache L, Niu X, Holroyd KJ, Roden DM, Skaar EP, Niswender CM, Marnett LJ, Lindsley CW, Ekstrom LB, Bentley AR, Bernard GR, Hong CC, Denny JC.

Assay Drug Dev Technol. 2017 Apr;15(3):113-119. doi: 10.1089/adt.2016.772. Epub 2017 Apr 5.

20.

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.

Luzum JA, Pakyz RE, Elsey AR, Haidar CE, Peterson JF, Whirl-Carrillo M, Handelman SK, Palmer K, Pulley JM, Beller M, Schildcrout JS, Field JR, Weitzel KW, Cooper-DeHoff RM, Cavallari LH, O'Donnell PH, Altman RB, Pereira N, Ratain MJ, Roden DM, Embi PJ, Sadee W, Klein TE, Johnson JA, Relling MV, Wang L, Weinshilboum RM, Shuldiner AR, Freimuth RR; Pharmacogenomics Research Network Translational Pharmacogenetics Program.

Clin Pharmacol Ther. 2017 Sep;102(3):502-510. doi: 10.1002/cpt.630. Epub 2017 Jun 9.

21.

Eliciting preferences on secondary findings: the Preferences Instrument for Genomic Secondary Results.

Brothers KB, East KM, Kelley WV, Wright MF, Westbrook MJ, Rich CA, Bowling KM, Lose EJ, Bebin EM, Simmons S, Myers JA, Barsh G, Myers RM, Cooper GM, Pulley JM, Rothstein MA, Clayton EW.

Genet Med. 2017 Mar;19(3):337-344. doi: 10.1038/gim.2016.110. Epub 2016 Aug 25.

22.

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab.

Rubbert-Roth A, Sebba A, Brockwell L, Kelman A, Porter-Brown B, Pulley J, Napalkov P, van Vollenhoven RF.

RMD Open. 2016 May 10;2(1):e000213. doi: 10.1136/rmdopen-2015-000213. eCollection 2016.

23.

Physician response to implementation of genotype-tailored antiplatelet therapy.

Peterson JF, Field JR, Unertl KM, Schildcrout JS, Johnson DC, Shi Y, Danciu I, Cleator JH, Pulley JM, McPherson JA, Denny JC, Laposata M, Roden DM, Johnson KB.

Clin Pharmacol Ther. 2016 Jul;100(1):67-74. doi: 10.1002/cpt.331. Epub 2016 Feb 17.

24.

A prognostic model based on readily available clinical data enriched a pre-emptive pharmacogenetic testing program.

Schildcrout JS, Shi Y, Danciu I, Bowton E, Field JR, Pulley JM, Basford MA, Gregg W, Cowan JD, Harrell FE Jr, Roden DM, Peterson JF, Denny JC.

J Clin Epidemiol. 2016 Apr;72:107-15. doi: 10.1016/j.jclinepi.2015.08.028. Epub 2015 Nov 25.

25.

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.

Gabay C, McInnes IB, Kavanaugh A, Tuckwell K, Klearman M, Pulley J, Sattar N.

Ann Rheum Dis. 2016 Oct;75(10):1806-12. doi: 10.1136/annrheumdis-2015-207872. Epub 2015 Nov 27.

26.

Practical considerations in genomic decision support: The eMERGE experience.

Herr TM, Bielinski SJ, Bottinger E, Brautbar A, Brilliant M, Chute CG, Cobb BL, Denny JC, Hakonarson H, Hartzler AL, Hripcsak G, Kannry J, Kohane IS, Kullo IJ, Lin S, Manzi S, Marsolo K, Overby CL, Pathak J, Peissig P, Pulley J, Ralston J, Rasmussen L, Roden DM, Tromp G, Uphoff T, Weng C, Wolf W, Williams MS, Starren J.

J Pathol Inform. 2015 Sep 28;6:50. doi: 10.4103/2153-3539.165999. eCollection 2015.

27.

Recommendations to Facilitate Expanded Access to Investigational Therapies for Seriously Ill Patients.

Jerome RN, Edwards TL, Boswell HC, Bernard GR, Harris PA, Pulley JM.

Acad Med. 2016 Mar;91(3):305-9. doi: 10.1097/ACM.0000000000000914.

28.

A conceptual model for translating omic data into clinical action.

Herr TM, Bielinski SJ, Bottinger E, Brautbar A, Brilliant M, Chute CG, Denny J, Freimuth RR, Hartzler A, Kannry J, Kohane IS, Kullo IJ, Lin S, Pathak J, Peissig P, Pulley J, Ralston J, Rasmussen L, Roden D, Tromp G, Williams MS, Starren J.

J Pathol Inform. 2015 Aug 31;6:46. doi: 10.4103/2153-3539.163985. eCollection 2015.

29.

Attitudes of clinicians following large-scale pharmacogenomics implementation.

Peterson JF, Field JR, Shi Y, Schildcrout JS, Denny JC, McGregor TL, Van Driest SL, Pulley JM, Lubin IM, Laposata M, Roden DM, Clayton EW.

Pharmacogenomics J. 2016 Aug;16(4):393-8. doi: 10.1038/tpj.2015.57. Epub 2015 Aug 11.

30.

Phenotype-Driven Plasma Biobanking Strategies and Methods.

Bowton EA, Collier SP, Wang X, Sutcliffe CB, Van Driest SL, Couch LJ, Herrera M, Jerome RN, Slebos RJ, Alborn WE, Liebler DC, McNaughton CD, Mernaugh RL, Wells QS, Brown NJ, Roden DM, Pulley JM.

J Pers Med. 2015 May 14;5(2):140-52. doi: 10.3390/jpm5020140.

31.

Tackling the "so what" problem in scientific research: a systems-based approach to resource and publication tracking.

Harris PA, Kirby J, Swafford JA, Edwards TL, Zhang M, Yarbrough TR, Lane LD, Helmer T, Bernard GR, Pulley JM.

Acad Med. 2015 Aug;90(8):1043-50. doi: 10.1097/ACM.0000000000000732.

32.

The Mid-South clinical Data Research Network.

Rosenbloom ST, Harris P, Pulley J, Basford M, Grant J, DuBuisson A, Rothman RL.

J Am Med Inform Assoc. 2014 Jul-Aug;21(4):627-32. doi: 10.1136/amiajnl-2014-002745. Epub 2014 May 12.

33.

Biobanks and electronic medical records: enabling cost-effective research.

Bowton E, Field JR, Wang S, Schildcrout JS, Van Driest SL, Delaney JT, Cowan J, Weeke P, Mosley JD, Wells QS, Karnes JH, Shaffer C, Peterson JF, Denny JC, Roden DM, Pulley JM.

Sci Transl Med. 2014 Apr 30;6(234):234cm3. doi: 10.1126/scitranslmed.3008604.

34.

The CTSA Consortium's Catalog of Assets for Translational and Clinical Health Research (CATCHR).

Shirey-Rice J, Mapes B, Basford M, Zufelt A, Wehbe F, Harris P, Alcorn M, Allen D, Arnim M, Autry S, Briggs MS, Carnegie A, Chavis-Keeling D, De La Pena C, Dworschak D, Earnest J, Grieb T, Guess M, Hafer N, Johnson T, Kasper A, Kopp J, Lockie T, Lombardo V, McHale L, Minogue A, Nunnally B, O'Quinn D, Peck K, Pemberton K, Perry C, Petrie G, Pontello A, Posner R, Rehman B, Roth D, Sacksteder P, Scahill S, Schieri L, Simpson R, Skinner A, Toussant K, Turner A, Van der Put E, Wasser J, Webb CD, Williams M, Wiseman L, Yasko L, Pulley J.

Clin Transl Sci. 2014 Apr;7(2):100-7. doi: 10.1111/cts.12144. Epub 2014 Jan 23.

35.

Patient awareness and approval for an opt-out genomic biorepository.

Brothers KB, Westbrook MJ, Wright MF, Myers JA, Morrison DR, Madison JL, Pulley JM, Clayton EW.

Per Med. 2013 Jun;10(4). doi: 10.2217/pme.13.34.

36.

Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data.

Denny JC, Bastarache L, Ritchie MD, Carroll RJ, Zink R, Mosley JD, Field JR, Pulley JM, Ramirez AH, Bowton E, Basford MA, Carrell DS, Peissig PL, Kho AN, Pacheco JA, Rasmussen LV, Crosslin DR, Crane PK, Pathak J, Bielinski SJ, Pendergrass SA, Xu H, Hindorff LA, Li R, Manolio TA, Chute CG, Chisholm RL, Larson EB, Jarvik GP, Brilliant MH, McCarty CA, Kullo IJ, Haines JL, Crawford DC, Masys DR, Roden DM.

Nat Biotechnol. 2013 Dec;31(12):1102-10.

37.

Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.

Van Driest SL, Shi Y, Bowton EA, Schildcrout JS, Peterson JF, Pulley J, Denny JC, Roden DM.

Clin Pharmacol Ther. 2014 Apr;95(4):423-31. doi: 10.1038/clpt.2013.229. Epub 2013 Nov 19.

38.

Models of interinstitutional partnerships between research intensive universities and minority serving institutions (MSI) across the Clinical Translational Science Award (CTSA) consortium.

Ofili EO, Fair A, Norris K, Verbalis JG, Poland R, Bernard G, Stephens DS, Dubinett SM, Imperato-McGinley J, Dottin RP, Pulley J, West A, Brown A, Mellman TA.

Clin Transl Sci. 2013 Dec;6(6):435-43. doi: 10.1111/cts.12118. Epub 2013 Oct 3.

39.

Electronic health record design and implementation for pharmacogenomics: a local perspective.

Peterson JF, Bowton E, Field JR, Beller M, Mitchell J, Schildcrout J, Gregg W, Johnson K, Jirjis JN, Roden DM, Pulley JM, Denny JC.

Genet Med. 2013 Oct;15(10):833-41. doi: 10.1038/gim.2013.109. Epub 2013 Sep 5.

40.

Ethical and practical challenges to studying patients who opt out of large-scale biorepository research.

Rosenbloom ST, Madison JL, Brothers KB, Bowton EA, Clayton EW, Malin BA, Roden DM, Pulley J.

J Am Med Inform Assoc. 2013 Dec;20(e2):e221-5. doi: 10.1136/amiajnl-2013-001937. Epub 2013 Jul 25.

41.

Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records.

Oetjens MT, Denny JC, Ritchie MD, Gillani NB, Richardson DM, Restrepo NA, Pulley JM, Dilks HH, Basford MA, Bowton E, Masys DR, Wilke RA, Roden DM, Crawford DC.

Pharmacogenomics. 2013 May;14(7):735-44. doi: 10.2217/pgs.13.64.

42.

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.

Shuldiner AR, Relling MV, Peterson JF, Hicks JK, Freimuth RR, Sadee W, Pereira NL, Roden DM, Johnson JA, Klein TE; Pharmacogenomics Research Network Translational Pharmacogenetics Program Group, Shuldiner AR, Vesely M, Robinson SW, Ambulos N Jr, Stass SA, Kelemen MD, Brown LA, Pollin TI, Beitelshees AL, Zhao RY, Pakyz RE, Palmer K, Alestock T, O'Neill C, Maloney K, Branham A, Sewell D, Relling MV, Crews K, Hoffman J, Cross S, Haidar C, Baker D, Hicks JK, Bell G, Greeson F, Gaur A, Reiss U, Huettel A, Cheng C, Gajjar A, Pappo A, Howard S, Hudson M, Pui CH, Jeha S, Evans WE, Broeckel U, Altman RB, Gong L, Whirl-Carrillo M, Klein TE, Sadee W, Manickam K, Sweet KM, Embi PJ, Roden D, Peterson J, Denny J, Schildcrout J, Bowton E, Pulley J, Beller M, Mitchell J, Danciu I, Price L, Pereira NL, Weinshilboum R, Wang L, Johnson JA, Nelson D, Clare-Salzler M, Elsey A, Burkley B, Langaee T, Liu F, Nessl D, Dong HJ, Lesko L, Freimuth RR, Chute CG.

Clin Pharmacol Ther. 2013 Aug;94(2):207-10. doi: 10.1038/clpt.2013.59. Epub 2013 Mar 19. No abstract available.

43.

Genome- and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk.

Ritchie MD, Denny JC, Zuvich RL, Crawford DC, Schildcrout JS, Bastarache L, Ramirez AH, Mosley JD, Pulley JM, Basford MA, Bradford Y, Rasmussen LV, Pathak J, Chute CG, Kullo IJ, McCarty CA, Chisholm RL, Kho AN, Carlson CS, Larson EB, Jarvik GP, Sotoodehnia N; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) QRS Group, Manolio TA, Li R, Masys DR, Haines JL, Roden DM.

Circulation. 2013 Apr 2;127(13):1377-85. doi: 10.1161/CIRCULATIONAHA.112.000604. Epub 2013 Mar 5.

44.

Response to "Doubt about the feasibility of preemptive genotyping".

Denny JC, Schildcrout JS, Pulley JM, Roden DM.

Clin Pharmacol Ther. 2013 Mar;93(3):234. doi: 10.1038/clpt.2012.223. Epub 2012 Nov 7. No abstract available.

PMID:
23249779
45.

Strategies for personalized medicine-based research and implementation in the clinical workflow.

Lieb W, Völzke H, Pulley JM, Roden DM, Kroemer HK.

Clin Pharmacol Ther. 2012 Oct;92(4):443-5. doi: 10.1038/clpt.2012.119. Epub 2012 Aug 22. Review.

PMID:
22910438
46.

Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.

Schildcrout JS, Denny JC, Bowton E, Gregg W, Pulley JM, Basford MA, Cowan JD, Xu H, Ramirez AH, Crawford DC, Ritchie MD, Peterson JF, Masys DR, Wilke RA, Roden DM.

Clin Pharmacol Ther. 2012 Aug;92(2):235-42. doi: 10.1038/clpt.2012.66. Epub 2012 Jun 27.

47.

Clinical and translational research studios: a multidisciplinary internal support program.

Byrne DW, Biaggioni I, Bernard GR, Helmer TT, Boone LR, Pulley JM, Edwards T, Dittus RS.

Acad Med. 2012 Aug;87(8):1052-9.

48.

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.

Pulley JM, Denny JC, Peterson JF, Bernard GR, Vnencak-Jones CL, Ramirez AH, Delaney JT, Bowton E, Brothers K, Johnson K, Crawford DC, Schildcrout J, Masys DR, Dilks HH, Wilke RA, Clayton EW, Shultz E, Laposata M, McPherson J, Jirjis JN, Roden DM.

Clin Pharmacol Ther. 2012 Jul;92(1):87-95. doi: 10.1038/clpt.2011.371. Epub 2012 May 16.

49.

Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS).

CTSA Principal Investigators, Shamoon H, Center D, Davis P, Tuchman M, Ginsberg H, Califf R, Stephens D, Mellman T, Verbalis J, Nadler L, Shekhar A, Ford D, Rizza R, Shaker R, Brady K, Murphy B, Cronstein B, Hochman J, Greenland P, Orwoll E, Sinoway L, Greenberg H, Jackson R, Coller B, Topol E, Guay-Woodford L, Runge M, Clark R, McClain D, Selker H, Lowery C, Dubinett S, Berglund L, Cooper D, Firestein G, Johnston SC, Solway J, Heubi J, Sokol R, Nelson D, Tobacman L, Rosenthal G, Aaronson L, Barohn R, Kern P, Sullivan J, Shanley T, Blazar B, Larson R, FitzGerald G, Reis S, Pearson T, Buchanan T, McPherson D, Brasier A, Toto R, Disis M, Drezner M, Bernard G, Clore J, Evanoff B, Imperato-McGinley J, Sherwin R, Pulley J.

Clin Transl Sci. 2012 Apr;5(2):121-9. doi: 10.1111/j.1752-8062.2012.00401.x. Epub 2012 Mar 27.

50.

Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record.

Ramirez AH, Shi Y, Schildcrout JS, Delaney JT, Xu H, Oetjens MT, Zuvich RL, Basford MA, Bowton E, Jiang M, Speltz P, Zink R, Cowan J, Pulley JM, Ritchie MD, Masys DR, Roden DM, Crawford DC, Denny JC.

Pharmacogenomics. 2012 Mar;13(4):407-18. doi: 10.2217/pgs.11.164. Epub 2012 Feb 13.

Supplemental Content

Loading ...
Support Center